ACAD vs CRNX
ACADIA Pharmaceuticals Inc. · Crinetics Pharmaceuticals, Inc.
Relative return (rebased to 100)
Key stats
| Metric | ACAD | CRNX |
|---|---|---|
| Price | $28.45 | $83.92 |
| Market Cap | $4.87B | $8.85B |
| P/E | 12.46 | — |
| P/B | 3.90 | 6.91 |
| P/S | 4.55 | 1149.76 |
| ROE | 31.3% | -36.3% |
| Net Margin | 36.5% | -6046.2% |
| Gross Margin | 63.9% | — |
| Revenue Growth | 11.9% | 640.7% |
| Dividend Yield | — | — |
| EPS | $2.28 | -$4.41 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.